In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

Analyst Silvan Tuerkcan of JMP Securities maintained a Buy rating on Terns Pharmaceuticals (TERN – Research Report), retaining the price ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

including those discussed under the heading "Risk Factors" in Arcturus’ most recent Annual Report on Form 10-K, and in subsequent filings with, or submissions to, the SEC, which are available on the ...

Biopharma financing continued to excel through the first 10 months of 2024, reaching $93.64 billion, a 53% increase from $61.04 billion during the same period in 2023.

Zealand Pharma A/S briefly reclaimed its position as this year’s ... the Danish biotech firm’s experimental weight-loss drug ...

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

Regulating drug discovery and pharmaceutical manufacturing, the FDA ensures the safety and effectiveness of innovative ...

Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...

One of the major opportunities in healthcare today is disrupting the status quo in pharmaceuticals. Hims & Hers (NYSE: HIMS) has brought a new model to the market and is growing extremely rapidly ...

TrueMed, a leading provider of anti-counterfeiting technology solutions, is proud to announce its new partnership with a Top 10 global pharmaceutical company to bolster the integrity of its ...

In a statement, the BoI said it participated in a US Agency for International Development (USAID) program studying the pharmaceutical ecosystem. The BoI, USAID, other National Government agencies, and ...